Event owner lens
Use this record to benchmark whether a comparable event makes the work after the room visible. The score is 32/100, so the next move is to benchmark the weakest pillars before repeating the format.
applied learning or working session agenda analysis
Magnus Group Conferences - 10th Edition of World Congress on Infectious Diseases - Scientific Sessions - 5. Infe
This applied learning or working session in Academic / Research / Science shows 80 visible agenda rows from infectiouscongress.com and scores 32/100: a thin but inspectable design signal. The clearest public signals sit in Participation Architecture and Personalization; the main limits are Follow Through and Network Design. Visible mechanisms include Participant work, Learning transfer, and Personalization. The public record does not show follow-up or tracking, so the score should be read as design intent rather... A practical reading: For a reader, this is a comparison record more than a model to copy: it reads as an applied learning or working session, with the strongest visible signal in participation architecture and personalization and the biggest open question around follow through and network design. The practical test is whether the published agenda connects the room to post-event continuation and evidence. This page is an original public-evidence analysis, not a copy of the source agenda or an endorsement of the event. The score places the visible agenda in the thin outcome architecture band. The strongest visible pillars are Participation Architecture, Personalization, and Learning Transfer; the thinnest visible pillars are Follow Through, Network Design, and Evidence Maturity. Visible mechanisms include Participant work, Learning transfer, and Personalization. The extracted agenda preview includes 80 visible rows. The most common formats are Unknown, Workshop, and Presentation; the most common inferred purposes are Unknown, Co Creation, and Knowledge Transfer.
Eight-pillar fingerprint
Hover any pillar to see what it measures and, where it scored low, what the agenda is missing.
Participation Architecture?59
Participation Architecture - 59/100. Participant work, contribution, interaction, and alternatives to passive broadcast.
Follow Through?5
Follow Through - 5/100. Owners, dates, commitments, progress checks, and accountability after the room.Missing: Add named owners, dates, implementation checkpoints, and a visible post-event continuation path.
Problem Specificity?32
Problem Specificity - 32/100. A clear costly problem, objective, decision, or performance target.
Personalization?46
Personalization - 46/100. Role, path, goal, preparation, or connection tailoring for participants.
Network Design?6
Network Design - 6/100. Structured weak ties, bridge-building, mixers, and relationship persistence.Missing: Replace generic networking blocks with designed introductions, ask-offer exchanges, peer groups, or bridge-building rituals.
Learning Transfer?35
Learning Transfer - 35/100. Applied practice, feedback, workplace use, refreshers, and 30-90 day transfer.
Evidence Maturity?31
Evidence Maturity - 31/100. Baseline, comparison, follow-up, isolation, and attribution confidence.Missing: Add baseline measurement, comparison logic, tracking, or post-event impact reporting so effectiveness is not inferred only from format.
Future-of-Work Fit?34
Future-of-Work Fit - 34/100. Value against time, hybrid reality, accessibility, AI, and meeting load.
Fix the gaps
Field-tested exercises matched to this agenda's weakest pillars, from the exercise library.
Follow Through (5/100)
Exercises that strengthen it: Mental Toughness Workshop • WorkshopBank · 15% Solutions • WorkshopBank · Network Patches
Network Design (6/100)
Exercises that strengthen it: Fun Trust-Building Group Game for Team Connection - Izzat... · Exciting Group Trust Activity for Building Confidence... · PFP: September 2005
Problem Specificity (32/100)
Exercises that strengthen it: 0 - “Two Person Scene” Theory · Challenge Axis - Knowmium: The Un-Training Consultancy · Fist to Five • WorkshopBank
Agenda Preview
The actual agenda we captured. Every block is classified by format and purpose. Open any block to see how we read it; the colored edge shows whether it is participant work, broadcast, logistics, or a showcase.
Room vs wrapper
41 percent of the 80 classified blocks put participants to work; the rest broadcast, show, or handle logistics. That mix is what drives the participation score.
Participant workBroadcastShowcaseLogistics
all eventScientific SessionsPresentationKnowledge Transfer+
Format · BroadcastPresentationSpeakers present, the audience receives. Awareness only unless paired with practice or follow-up.
Evidence basisMediumRead from source
all eventScientific ProgramUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventSubclinical and asymptomatic infections can pose significant challenges in disease control, as individuals carrying the infection may not display noticeable symptoms but can still transmit the pathogen to others. Subclinical and asymptomatic infections are common in many infectious diseases, including viral infections like HIV, and bacterial infections like tuberculosis. These infections can often go unnoticed, making it difficult to identify and isolate carriers early. Despite the absence of symptoms, these individuals may still suffer long-term health effects, and their role in the spread of the disease can lead to outbreaks. Understanding the dynamics of subclinical and asymptomatic infections is vital for improving surveillance, testing, and public health interventions aimed at controlling infectious diseases.WorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all event1. Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event2. Coronavirus Disease (COVID-19)UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event3. Pediatric Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event4. STD and HIV InfectionUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event5. Infectious Diseases Prevention, Control and CureUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event6. Infection, Immunity and InflammationUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event7. Pharmacology of Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event8. Blood Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event9. EpidemiologyUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event10. Sepsis/SepticemiaUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event11. Ebola and Zika Viral InfectionsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event12. Emerging and Re-Emerging Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event13. Antimicrobial Resistance (AMR)UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event14. Vaccine Development and ImmunizationUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event15. Global Health and Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event16. Viral Infections and VirologyUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event17. Genomics and Bioinformatics in Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event18. Infectious Diseases Diagnostics and ImagingUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event19. Infection Control and Hospital-Acquired InfectionsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event20. Infectious Diseases and AgingUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event21. Infectious Diseases and Public HealthUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event22. Innovative Therapies and Drug DiscoveryUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event23. Artificial Intelligence and Big Data in Infectious Disease ManagementUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event24. Behavioral and Social Aspects of Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event25. Non-Communicable Diseases and InfectionsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event26. Emerging Technologies in Infectious Disease ManagementUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event27. Infectious Diseases and NeurologyUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event28. Clinical Case ReportsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all event29. Pandemic Preparedness: Global Strategies for Mitigation and ResponseUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event30. Airborne, Waterborne and Foodborne DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event31. Infectious Diseases in Immunocompromised HostsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event32. One Health Approach to Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event33. Veterinary Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event34. Tropical and Neglected Tropical DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event35. Early Symptoms of Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event36. Infectious Disease ResearchUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event37. Climate Change and Infectious DiseasesUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all event38. Subclinical and Asymptomatic InfectionsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all event39. Bacterial, Fungal, and Parasitic InfectionsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventKeynote Presentation (In-Person)KeynoteThought Leadership+
Format · BroadcastKeynoteA featured talk from the stage. Builds awareness and energy, produces no participant output on its own.
Evidence basisMediumRead from source
all eventTitle : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasuresUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventView ProfileUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventTitle : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variantsUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventTitle : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infectionsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventTitle : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatmentUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventTitle : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030UnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventTitle : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle managementUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventView Full Scientific ProgramUnknownUnknown+
Format · BroadcastUnknownFormat not classified from the source; treated as a broadcast block by default.
Evidence basisLowRead from source
all eventSubclinical and Asymptomatic Infections ConferencesWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections ConferenceWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections EventsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections Congress 2026WorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections Hybrid EventsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections WebinarsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections SeminarsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections Meetings 2026WorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections WorkshopsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections Virtual ConferenceWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections Symposium 2026WorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections Online EventWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections Hybrid EventWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections SummitWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections ExpoWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventUpcoming Subclinical and Asymptomatic Infections ConferenceWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventInternational Subclinical and Asymptomatic Infections Conferences 2026WorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventGlobal Subclinical and Asymptomatic Infections CongressWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections Hybrid WebinarWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections Hybrid SeminarWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventInternational Conference on Subclinical and Asymptomatic Infections 2026WorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventGlobal Congress on Subclinical and Asymptomatic InfectionsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventInternational Summit on Subclinical and Asymptomatic InfectionsWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections SeminarWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections Meeting 2026WorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections WorkshopWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventUpcoming Subclinical and Asymptomatic Infections CongressWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventUpcoming Subclinical and Asymptomatic Infections EventWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
all eventSubclinical and Asymptomatic Infections EventWorkshopCo Creation+
Format · Participant workWorkshopParticipants work on a problem and produce something. The strongest signal of participation architecture.
Evidence basisMediumRead from source
The Full Reading
Why It Ranks This Way +
Calibrated from GES design 31/100 and verified 31/100 with no fourth-loop cap.
Reader Takeaway. For a reader, this is a comparison record more than a model to copy: it reads as an applied learning or working session, with the strongest visible signal in participation architecture and personalization and the biggest open question around follow through and network design. The practical test is whether the published agenda connects the room to post-event continuation and evidence.
Strongest signals: Participation Architecture, Personalization, and Learning Transfer. Weakest signals: Follow Through, Network Design, and Evidence Maturity.
How This Agenda Could Improve +
- Add named owners, dates, implementation checkpoints, and a visible post-event continuation path.
- Replace generic networking blocks with designed introductions, ask-offer exchanges, peer groups, or bridge-building rituals.
- Add baseline measurement, comparison logic, tracking, or post-event impact reporting so effectiveness is not inferred only from format.
Fastest next move: Add named owners, dated next steps, and a visible continuation path before treating the event as outcome-ready.
Role-Specific Reading +
Sponsor lens
Look beyond exposure. Strong sponsor value would show qualified interaction, problem work, buyer learning, customer evidence, or follow-up. The practical sponsor move is to ask for qualified interaction and post-event proof, not only reach.
Designer lens
The agenda is useful as a pattern sample from infectiouscongress.com. Redesign attention should go first to the lowest-scoring pillars; in practice, turn the thinnest agenda blocks into participant work.
Executive lens
Treat the visible agenda as an operating plan. The executive move is to require owners, dates, and evidence before treating the event as strategic. If owners, proof, and follow-through are not visible, the public record does not yet prove strategic movement.
Aggregator lens
Treat the source URL as evidence, not decoration. The data-product move is to label the source boundary clearly before ranking the record before ranking or syndicating the record.
What GES Means Here +
The Gathering Effectiveness Score is a strict 0-100 public-evidence reading of the agenda across eight pillars. It rewards visible participant work, follow-through, transfer, network design, and proof mechanisms more than polish, speaker fame, attendance, or satisfaction.
Visible mechanisms: Participant work, Learning transfer, Personalization.
Evidence boundary: Scores reflect visible agenda/source evidence and should not be read as proof of causal event impact.
Limitations, Score Caps, and Review Flags +
Limitations
- No visible follow-up, progress monitoring, or longitudinal tracking.
- No baseline measurement is visible.
Score caps
- No fourth-loop score cap applied.
Review flags
- Judgment uses base extraction because no publication-polished agenda is available.
- No source-backed follow-up, validation, baseline, tracking, or impact evidence.
Is this proof the event worked? +
No. This is a strict public-evidence reading of the agenda. Proof would require baseline, comparison, follow-up, attribution, and impact evidence beyond the listing.
What should a reader inspect first? +
Start with the source URL, then compare the eight pillar scores against the agenda rows. The biggest opportunities usually sit in follow-through, evidence maturity, and participant work.
Why publish weak records? +
Weak records are part of the map. They show where public agendas still describe sessions and speakers more often than outcomes, commitments, transfer, or proof.
How should I use the rows? +
Read the agenda rows as the visible design trace: formats, purposes, and evidence labels show what the public source made inspectable, not everything that happened in the room. This is a source-grounded interpretation of the public agenda record, not a copy of the source, and not an endorsement of the event.
Where To Go Next
Compare this agenda against other Academic / Research / Science events scored on the same eight pillars.